Tn125-related acquisition of blaNDM-like genes in Acinetobacter baumannii

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 2, 2012, Pages 1087-1089

  Poirel, Laurent ^a   Bonnin, Rémy A ^a   Boulanger, Anne ^a   Schrenzel, Jacques ^b   Kaase, Martin ^c   Nordmann, Patrice ^a  

^a Associated French National Reference Center for Antibiotic Resistance: Carbapenemase producing Enterobacteriaceae   (France)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEMASE;

ACINETOBACTER BAUMANNII; ARTICLE; BACTERIUM ISOLATE; GENE; GENE EXPRESSION; GENE INSERTION SEQUENCE; GERMANY; HOSPITALIZATION; HUMAN; MULTIDRUG RESISTANCE; NDM 1 GENE; NDM 2 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SERBIA; SWITZERLAND; TRANSPOSON;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; CARBAPENEMS; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE TRANSFER, HORIZONTAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; SWITZERLAND;

EID: 84856073157     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05620-11     Document Type: Article

References (28)

1. Berçot B, Poirel L, Nordmann P. 2011. Updated multiplex PCR for detection of 16S rRNA methylases; high prevalence among NDM-1 producers. Diagn. Microbiol. Infect. Dis. 71:442-445.
2. CMY-2-positive IncA/C plasmids from Escherichia coli and Salmonella enterica are a distinct component of a larger lineage of plasmids. Antimicrob. Agents Chemother. 54:590-596.
3. Clinical Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing; 21st informational supplement. CLSI M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. 2010. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 5:e10034.
5. Di Popolo A, Giannouli M, Triassi M, Brisse S, Zarrilli R. 2011. Molecular epidemiological investigation of multidrug-resistant Acinetobacter baumannii strains in four Mediterranean countries with a multilocus sequence typing scheme. Clin. Microbiol. Infect. 17:197-201.
6. Göttig S, et al. 2010. Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect. Dis. 10:828-829.
7. Iacono M, et al. 2008. Whole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II group. Antimicrob. Agents Chemother. 52:2616-2625. (Pubitemid 351915695)
8. Johnson TJ, Wannemeuhler YM, Scaccianoce JA, Johnson SJ, Nolan LK. 2006. Complete DNA sequence, comparative genomics, and prevalence of an IncHI2 plasmid occurring among extraintestinal pathogenic Escherichia coli isolates. Antimicrob. Agents Chemother. 50:3929-3933. (Pubitemid 44684920)
9. Kaase M, et al. 2011. NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J. Antimicrob. Chemother. 66:1260-1262.
10. NDM-1 and armA in clinical isolates of Acinetobacter baumannii from India. J. Antimicrob. Chemother. 65:2253-2254.
11. Reference deleted.
12. Kumarasamy KK, et al. 2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis. 10:597-602.
13. Livermore DM, Walsh TR, Toleman M, Woodford N. 2011. Balkan NDM-1: escape or transplant? Lancet Infect. Dis. 11:164.
14. Mezzatesta ML, et al. Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy. Clin. Microbiol. Infect., in press.
15. OXA-18, encoding a clavulanic acid-inhibited extended-spectrum oxacillinase. Antimicrob. Agents Chemother. 52:3898-3904.
16. Nordmann P, Naas T, Poirel L. 2011. Global spread of carbapenemase- producing Enterobacteriaceae. Emerg. Infect. Dis. 17:1791-1798.
17. Nordmann P, Poirel L, Toleman MA, Walsh TR. 2011. Does broad spectrum β-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? J. Antimicrob. Chemother. 66:689-692.
18. NDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007. J. Antimicrob. Chemother. 66:1998-2001.
19. Poirel L, Bonnin RA, Nordmann P. 2011. Analysis of the resistome of a multidrug-resistant NDM-1-producing Escherichia coli strain by high-throughput genome sequencing. Antimicrob. Agents Chemother. 55:4224-4229.
20. NDM-1-positive Enterobacteriaceae. Antimicrob. Agents Chemother. 55:5403-5407.
21. Poirel L, Fortineau N, Nordmann P. 2011. International transfer of NDM-1-producing Klebsiella pneumoniae from Iraq to France. Antimicrob. Agents Chemother. 55:1821-1822.
22. Poirel L, et al. 2011. Molecular analysis of NDM-1-producing enterobacterial isolates from Geneva, Switzerland. J. Antimicrob. Chemother. 66:1730-1733.
23. Poirel L, Walsh TR, Cuvillier V, Nordmann P. 2011. Multiplex PCR for detection of acquiredcarbapenemasegenes. Diagn. Microbiol. Infect. Dis.70:119-123.
24. Rodriguez-Martinez J-M, Nordmann P, Fortineau N, Poirel L. 2010. VIM-19, a metallo-β-lactamase with increased carbapenemase activity from Escherichia coli and Klebsiella pneumoniae. Antimicrob. Agents Chemother. 54:471-476.
25. Toleman MA, Bennett PM, Walsh TR. 2006. ISCR elements: novel gene-capturing systems of the 21st century? Microbiol. Mol. Biol. Rev. 70:296-316. (Pubitemid 43898667)
26. Toleman MA, Walsh TR. 2008. Evolution of the ISCR3 group of ISCR elements. Antimicrob. Agents Chemother. 52:3789-3791.
27. Wang Y-D, Zhao S, Hill CW. 1998. Rhs elements comprise three subfamilies which diverged prior to acquisition by Escherichia coli. J. Bacteriol. 180:4102-4110. (Pubitemid 28373512)
28. Welch TJ, et al. 2007. Multiple antimicrobial resistance in plague: an emerging public health risk. PLoS One 2:e309.